<DOC>
<DOCNO>
EP-0001238
</DOCNO>
<TEXT>
<DATE>
19790404
</DATE>
<IPC-CLASSIFICATIONS>
C07D-405/06 A61K-31/513 A61K-31/495 <main>C07D-233/78</main> A61P-7/02 C07D-409/00 C07D-233/90 A61K-31/415 A61P-9/08 C07D-233/76 C07D-239/00 A61P-7/00 C07D-403/00 C07D-405/00 A61K-31/4166 A61K-20060101S C07D-233/78 A61K-31/4164 C07D-233/74 C07D-409/06 C07D-233/72 C07D-401/00 C07D-403/06 C07D-233/00 A61P-9/00 C07D-403/12 A61P-9/12 C07D-20060101S 
</IPC-CLASSIFICATIONS>
<TITLE>
hydantoin derivatives, their synthesis, pharmaceutical formulations and intermediates in their preparation.
</TITLE>
<APPLICANT>
wellcome foundgb<sep>the wellcome foundation limited<sep>the wellcome foundation limitedunicorn house 160 euston road p.o. box 129london nw1 2bpgb<sep>the wellcome foundation limited<sep>
</APPLICANT>
<INVENTOR>
caldwell albert gordon<sep>whittaker norman<sep>caldwell, albert gordon<sep>whittaker, norman<sep>caldwell, albert gordon119 gates green roadwest wickham kentgb<sep>whittaker, norman37 brabourne risebeckenham kentgb<sep>caldwell, albert gordon<sep>whittaker, norman<sep>caldwell, albert gordon119 gates green roadwest wickham kentgb<sep>whittaker, norman37 brabourne risebeckenham kentgb<sep>
</INVENTOR>
<ABSTRACT>
substituted hydantoins with formula    wherein z is hydrogen or alkyl and z¹ and z² represent the  usual prostaglandin chains, having pharmacological properties  related to those of prostaglandins and are useful in  medicine, for example in the treatment of thrombosis.  
</ABSTRACT>
</TEXT>
</DOC>
